Actinoporins are eukaryotic pore-forming proteins that create 2-nm pores in natural and model lipid membranes by the self-association of four monomers. The regions that undergo conformational change and form part of the transmembrane pore are currently being defined. It was shown recently that the N-terminal region (residues 10 -28) of equinatoxin, an actinoporin from Actinia equina, participates in building of the final pore wall. Assuming that the pore is formed solely by a polypeptide chain, other parts of the toxin should constitute the conductive channel and here we searched for these regions by disulfide scanning mutagenesis. Only double cysteine mutants where the N-terminal segment 1-30 was attached to the ␤-sandwich exhibited reduced hemolytic activity upon disulfide formation, showing that other parts of equinatoxin, particularly the ␤-sandwich and importantly the C-terminal ␣-helix, do not undergo large conformational rearrangements during the pore formation. The role of the ␤-sandwich stability was independently assessed via destabilization of a part of its hydrophobic core by mutations of the buried Trp 117 . These mutants were considerably less stable than the wild-type but exhibited similar or slightly lower permeabilizing activity. Collectively these results show that a flexible N-terminal region and stable ␤-sandwich are pre-requisite for proper pore formation by the actinoporin family.
Interaction of proteins with lipid membranes is fundamental for many biological processes. Proteins have to bind transiently or permanently to the membranes to elicit biological functions crucial for cells (1) . Many examples of protein-membrane interactions are known, most notably those involved in cell signaling events (2) (3) (4) . Furthermore, a large number of protein toxins attach to membranes as the first step in creating transmembrane pores that are permeable for various compounds (5) . The lipid membrane is the first obstacle that needs to be overcome by toxins and in fact creation of transmembrane pores is a very efficient way of killing cells. Pore-forming toxins (PFTs) 1 are thus a very important group of natural toxins (6) , and the best studied examples are bacterial PFTs, because they are also important virulence factors in human and animal bacterial disease. In recent years they have been used to study fundamental biological processes such as protein-membrane and protein-protein interactions within the lipid membrane milieu and conformational changes associated with the change of environment from polar to hydrophobic as encountered within the core of lipid membranes.
In general all PFTs intoxicate cells by a multistep mechanism that involves binding to the membrane, oligomerization, and transfer of a region of polypeptide across the lipid bilayer to form a functional pore (5) . Heterogeneous PFTs can be divided into two groups according to the structural element present in the final pore. So-called ␤-PFTs form pores by creation of transmembrane ␤-barrels. Examples include ␣-toxin from Staphylococcus aureus, cholesterol-dependent cytolysins and anthrax protective antigen (7) . In contrast, ␣-PFTs, like colicins from Escherichia coli, form pores by bundles of ␣-helices (8) . Although pores of ␤-PFTs are stable structures that resist heat or detergents, ␣-PFT pores are not stable and have provided little structural information.
Actinoporins are a group of eukaryotic PFTs that are very important in our understanding of how ␣-PFTs function (9, 10). These 20-kDa, mainly basic, proteins can efficiently lyse various cells and permeabilize model lipid membranes by using an ␣-helix in a mechanism that is slowly being defined in vitro (11) (12) (13) (14) (15) (16) (17) (18) . Actinoporins represent a unique family of cysteineless proteins with high sequence similarity (10) . The two most studied examples are equinatoxin II (EqtII) from the sea anem-one Actinia equina and sticholysin II (StII) from Stichodactyla helianthus. They are both globular proteins composed of a tightly folded ␤-sandwich flanked on two sides by ␣-helices (Fig. 1, A and B) (11, 12, 17) . The N-terminal segment containing an amphipathic ␣-helix (helix A) is the only part of the molecule that can be displaced without disrupting the ␤-sandwich fold. Actinoporins strictly follow the multistep scheme of pore formation. The initial attachment to the membrane is achieved by a cluster of aromatic amino acid residues from one of the broad loops at the bottom of the ␤-sandwich and helix B (13, 19, 20) and by a recently defined phosphorylcholine (POC) binding site (17) . In the next step the segment 10 -28 is transferred to the lipid-water interface (13, 15) , where it lies flat on the membrane (15) and, finally, in the last step forms the walls of the final pore (15) . The final oligomeric pore of actinoporins has not yet been directly visualized. Instead, the number of monomers was deduced only from the cross-linking studies and kinetic experiments. Both, EqtII and StII, form 2-nm pores in diameter composed of four monomers (21) (22) (23) (24) .
Pores of such a diameter cannot be simply formed by a cluster of four helices (Fig. 1D) . Either other parts of the molecule contribute to the final oligomeric conductive pore, or the pore is composed partially of lipid molecules from the bilayer. The first possibility requires considerable unfolding of the ␤-sandwich and its rearrangements in such a way that remaining space between helices is filled with the polypeptide chain. A testable model has been proposed for EqtII involving the formation of a transmembrane ␤-barrel (12) . Each molecule would then contribute one ␤-hairpin, including residues 118 -142. This model requires a significant unfolding of the ␤ sandwich, because each hairpin would include ␤-strands 8 and 9 and C-terminal helix B.
The aim of this study is to test such models by clearly defining those regions of the EqtII molecule that undergo conformational rearrangements during the pore formation and which could therefore participate in the building of pore walls. We used disulfide scanning mutagenesis, because this technique was previously successfully used to determine conformationally flexible regions in PFTs (25) (26) (27) . The movement of polypeptide chain segments during pore formation can be restricted by a disulfide formation and viewed as a large decrease in permeabilizing activity. We show that apart from the Nterminal segment there are no other parts, specifically ␤-sandwich and helix B, that undergo gross conformational changes. Interestingly, mutations of broad loops at the bottom of the molecule abolished hemolytic activity completely, showing the need to preserve primary structure for pore formation. The need for an unperturbed ␤-sandwich was further and independently confirmed by destabilizing mutants in the ␤-sandwich. We propose that the flexible N-terminal segment and loops at the bottom of the molecule are the solely parts of the molecule directly involved in the steps that follow the initial binding, whereas the ␤-sandwich is maintained rigid during all steps of pore formation.
EXPERIMENTAL PROCEDURES
Materials-1,2-Dioleoyl-sn-glycero-3-phosphorylcholine (PC) and brain sphingomyelin (SM) were both from Avanti Polar Lipids (Alabaster, AL). All other materials were from Sigma, unless specified differently.
Mutant Design-Positions for mutations were selected first by the SSBond program (28) using EqtII crystal structure as a template (11) (PDB code 1IAZ). Additional mutants were selected by manually inspecting the structure and searching for amino acid pairs with suitable C ␤ -C ␤ distances (between 3.8 and 4.8 Å). These additional mutants were employed to cover all regions of the EqtII molecule. All selected pairs were analyzed by the Scwrl3 program (29) and Swiss-PDB Viewer (www.expasy.org/spdbv/) (30) . The most suitable rotamer was selected, either by program, in the case of Scwrl3, or manually by the use of Swiss-PDB Viewer, when Scwrl3 did not report in silico disulfide bridge formation. Disulfide bonds could be formed in silico by all mutants used in this study.
Cloning, Expression, and Isolation of Mutants-Double cysteine mutants and Trp 117 mutants were prepared by replacing the corresponding EqtII residue with the desired amino acid as described previously (31) . Wild-type EqtII and selected mutants were expressed in the E. coli BL21(DE3) strain and isolated from the bacterial cytoplasm exactly as described elsewhere (15, 31, 32) . All mutants were purified to homogeneity as observed on the SDS-PAGE gels.
Treatment of Mutants with Reductant or Oxidant-Double cysteine mutants were treated either with 20 mM dithiothreitol (DTT) or 0.5 mM 1,10-phenantroline and 0.1 mM CuSO 4 for 30 min at 37°C to obtain reduced or oxidized form of the mutants, respectively. These concentrations were sufficient to obtain fully oxidized or reduced samples. Samples were immediately used for hemolytic activity measurements or erythrocytes binding assay. DTT has no effect on cells in these tests, because it was always diluted below 2 mM.
Hemolytic Assay-Bacterial lysates were used to assay hemolytic activity of expressed double cysteine mutants. Mutants were expressed in E. coli BL21(DE3) strain. 20 ml of LB medium supplemented with 100 g/ml ampicillin was inoculated with 1 ml of overnight culture. The expression of proteins was induced with final concentration of 0.4 mM isopropyl-1-thio-␤-D-galactopyranoside, when bacteria reached an absorbance at 600 nm of ϳ0.6, and then grown for additional 4 h. To prepare lysates, bacterial cells were harvested by centrifugation at 4°C and 14,000 ϫ g for 10 min. Pellets were resuspended in 0.5 ml of 50 mM Tris-HCl, pH 8, containing ϳ2 mg/ml lysozyme. Incubation of samples at room temperature for 15 min was followed by a 30-s pulse of sonication. Supernatants were collected after centrifugation at 4°C and 14,000 ϫ g for 15 min. The pellets were washed with 0.25 ml of the same buffer, vortexed, sonicated, and centrifuged as above. Supernatants were merged and stored at Ϫ20°C before use. Hemolytic activity was measured turbidimetrically by the use of a microplate reader (MRX; Dynex Technologies, Deckendorf, Germany) (20) . A suspension of bovine red blood cells (BRBC) with A 630 ϭ 0.5 in hemolysis buffer (0.13 M NaCl, 0.02 M Tris-HCl, pH 7.4) was prepared from well washed BRBC. 100 l of BRBC suspension were added to 100 l of 2-fold serially diluted bacterial lysates or purified mutants. Hemolysis was monitored by measuring the absorbance at 630 nm for 20 min at room temperature. The amount of bacterial lysate used for the assay, where reduced and oxidized forms were compared, corresponded to the volume of the lysate that exhibits 50% of maximal hemolytic rate at the dilution 32 or 64 (6th or 7th well in the multiwell plate) in the presence of 2 mM DTT.
Binding of Double Cysteine Mutants to Erythrocytes-The binding assay was done as described in Hong et al. (13) . Briefly, 0.15 nmol of pretreated protein was incubated with BRBC suspension (A 700 ϭ 0.5) in erythrocyte buffer supplemented with 30 mM polyethylene glycol 3350 at 4°C. After 10 min of incubation, the samples were pelleted and electrophoresis loading buffer was added to the pellets containing erythrocytes with bound toxin. Bound proteins were resolved by SDS-PAGE electrophoresis and Western-blotted as described below.
SDS-PAGE Electrophoresis-Mini Protean II system (Bio-Rad) was used. 5 l of bacterial lysates or 0.15 nmol of purified toxins, treated with reductant or oxidant as described above, were mixed with the same volume of SDS-PAGE sample loading buffer (120.5 mM Tris-HCl, 4% SDS (w/v), 10% glycerol (v/v), and 0.002% (w/v) Bromphenol Blue). Proteins were resolved on 15% SDS-PAGE gels. The gels were stained with Coomassie Blue or Western-blotted. For blotting, proteins were transferred to polyvinylidene difluoride membranes (Millipore), blocked in 4% bovine serum albumin at 4°C overnight, and incubated with rabbit anti-EqtII serum for 2 h. Bands were stained with goat antirabbit antibodies conjugated with horseradish peroxidase using 3-amino-9-ethylcarbazole/H 2 O 2 .
Permeabilizing Assay Using Liposomes-Large unilamellar vesicles were prepared by extrusion of multilamellar vesicles. Lipids, dissolved in chloroform, were spread on the round-bottom glass flask on a rotary evaporator and dried under vacuum for at least 3 h. The lipid film was resuspended in 1 ml of 60 mM calcein in vesicle buffer (140 mM NaCl, 20 mM Tris-HCl, pH 8.5, 1 mM EDTA) and freeze-thawed six times. Large unilamellar vesicles of 100 nm were extruded through polycarbonate membranes with 100-nm pores by an Avestin lipid extruder (Avestin, Ottawa, Canada) (33) . The excess of calcein was removed from the calcein-loaded liposomes by gel filtration on a small G-50 column. For calcein release experiments, liposomes were stirred at the desired concentration at 25°C. Toxins were added at final 0.05 M concentration. Changes in the fluorescence intensity were followed on a Jasco FP-750 spectrofluorimeter. Excitation and emission wavelengths were set to 485 and 520 nm, respectively. Excitation and emission slits were set to 5 nm. The permeabilization induced by the toxins was expressed in percentage as compared with the maximal permeabilization obtained at the end of the assay by the addition of Triton X-100 at a final concentration of 2 mM.
Critical Pressure Measurements-A MicroTrough S system (Kibron, Helsinki, Finland) was used to perform surface pressure measurements. The aqueous phase consisted of 0.5 ml of 10 mM HEPES, 200 mM NaCl, pH 7.5, at room temperature. The PC/SM 1/1 mixture of lipids, dissolved in chloroform, was gently spread over the surface, until desired initial pressure was achieved. The protein was injected with a Hamilton microsyringe through a hole connected to the subphase. The final protein concentration was 1 M. The increment in surface pressure versus time was followed until a stable signal was obtained.
ANS Binding Assay-The fluorescence of 1-anilinonaphthalene-8-sulfonic acid (ANS) in the presence of EqtII or Trp 117 mutants in 10 mM HEPES, 200 mM NaCl, pH 7.5, was followed at 468 nm with excitation wavelength set to 370 nm. Excitation and emission slits were set to 5 nm. The cuvette was placed in a thermostatted cell holder, and the contents were stirred continuously. Measurements were taken between 15 and 75°C by using a 1°C/min heating rate. The concentration of ANS and protein was 15 and 6 M, respectively.
Circular Dichroism Spectroscopy-Circular dichroism (CD) spectra were measured in the far-UV region, 250 -185 nm, by Jasco J-810 spectropolarimeter. Bandwidth was set to 2 nm; scanning speed was 50 nm/min. Proteins were placed in a 1-mm path-length stoppered cuvette (Hellma) at 8 M concentration in 10 mM NaH 2 PO 4 , pH 7.0. The reported spectra are averages of 10 scans. The signal at 217 nm was followed for thermal denaturation that was performed between 20 -90°C at a heating rate of 1°C/min.
Crystallization and Data Collection-Crystals of EqtII double cysteine mutant Val 8 3 Cys, Lys 69 3 Cys (8 -69) were grown by the sitting drop vapor diffusion method. The reservoir contained 1 ml of 15% polyethylene glycol 4000, 0.12 M ammonium sulfate, 0.06 M sodium acetate, pH 6.0. The drop was composed of 3.7 l of reservoir solution and 2.3 l of the protein (10 mg/ml). Diffraction data were collected from a single crystal using CuK ␣ radiation from a Rigaku Ru200 rotating anode x-ray generator and recorded on a 345-mm MAR Research image plate detector. Auto indexing and scaling was done using HKL2000 (34) . The crystal diffracted to 2.3-Å resolution and belonged to the primitive monoclinic space group P2 1 with cell dimensions a ϭ 36.6 Å, b ϭ 52.7 Å, c ϭ 39.8 Å, ␤ ϭ 92.3°. The asymmetric unit contained one molecule.
Structure Determination and Refinement-The structure of 8 -69 mutant was solved by the molecular replacement method implemented in the AMoRe (35) program. The crystal structure of the wild-type equinatoxin (11) was used as the search model. In the subsequent structure determination, the program MAIN (36) was used for model building and refinement. The final refinement included all reflections in the resolution range 10 -2.3 Å, with the crystallographic R-value being 0.192. The geometry of the final model was inspected with MAIN and Procheck (37) . All residues lie in the allowed regions of the Ramachandran plot, 0.913 of residues in most favored regions and 0.087 in additional allowed regions. The coordinates have been deposited in the Protein Data Bank with the accession code 1TZQ.
RESULTS

Preparation of Double Cysteine Mutants-The wild-type
EqtII is produced in the active form in the cytoplasm of E. coli. The negative control, the soluble fraction of bacterial cells with pT7 expression vector without EqtII gene, is not hemolytically active (see Fig. 2 ) (32). Thus any hemolytic activity observed is due to expressed active toxin. The hemolytic assay we use routinely is very sensitive, because nanomolar concentrations of the toxin already produce detectable hemolysis. Conformational changes are expected during pore formation. By introducing two cysteines at appropriate positions in a cysteineless EqtII it is possible to block conformational changes upon disulfide formation. Therefore, twenty-five mutants were designed throughout the molecule covering the N-terminal region (6 mutants), the region around the C-terminal helix B (5 mutants), ␤-sandwich (11 mutants), and broad loops at the bottom of the molecule (3 mutants) ( Fig. 1 and Table I ). Positions for mutagenesis were determined by using the program SSBond using EqtII crystal structure as a template. Additional mutants were added to selection, although SSBond did not report them as favorable, on the basis of their C ␤ -C ␤ distances. The majority of mutants have this distance between 3.8 and 4.8 Å, one of the criteria that needs to be fulfilled for the disulfide formation. This set of mutants covers all regions proposed to be involved in conformational changes during the pore formation, thus enabling us to exclude regions that are not important.
All mutants were produced in an E. coli cytoplasm in comparable amounts to the wild-type EqtII as judged from gels and Western blots. Selected examples are presented in Fig. 2 . For mutants 14 -70 (the N-terminal region), 118 -136 (helix B), 31-77, 85-108, 107-113 (loops), and 87-105 (␤-sandwich) (the numbers indicate the position in EqtII sequence where a cysteine was introduced) no hemolytic activity was detected in the bacterial cytoplasm despite expressed protein ( Fig. 2 and Table  I ). The lack of activity could be due to the importance of some of these positions for the functioning of the protein. Interestingly, all mutants from the broad loops at the bottom of the molecule, were hemolytically inactive.
Hemolytic Activity of the Double Cysteine Mutants in Reduced and Oxidized Form-Mutants expressed in the bacterial cytoplasm were incubated with excess of DTT or with a mixture of CuSO 4 and 1,10-phenantroline to obtain fully reduced or oxidized forms, respectively. Hemolytic activity was then measured and compared for both states (Fig. 3A) . The summary for all mutants is shown on Fig. 4 . It is expressed as a ratio of the dilutions of the oxidized and reduced forms needed to obtain . D, the current model of EqtII pore structure. The contribution of polar face of the amphipathic helix formed by N-terminal part 10 -28 to the pore wall was shown recently (15) . The experimentally determined diameter of the pore is too large to be simply explained by the cluster of four helices, each of them from one EqtII molecule. Hydrophobic residues are shown as black circles; polar and charged ones are labeled as white circles.
half-maximal hemolytic rates. The activity of the wild-type was, as expected, not affected by the treatment due to lack of cysteines in the primary structure. The activity of the majority of the mutants remained unchanged for both states (ratio ϳ1). All mutants from the N-terminal part, with the exception of 11-38, were either not active or drastically (almost two orders of magnitude) inhibited in the oxidized state (ratio 0 -0.029). The lack of any change for mutant 11-38 is most probably due to lack of the disulfide bridge formed, no shift in the mobility of the oxidized form in comparison to the reduced one was observed for this mutant on SDS-PAGE gel (data not shown). The only mutant more active in the oxidized state was 54 -87 with a ratio of 4.4.
It is necessary to determine the degree of the oxidation, as intermolecular dimers or even high-order oligomers can be formed, and because the absence of any change in activity might be due to lack of the disulfide formation. As deduced from Western blots (not shown), all mutants, except 14 -38, remained monomers after oxidation, indicating that no intermolecular dimers were formed. In 14 -38, a small amount of dimers was always observed (Fig. 3C) , however, the amount was too small to explain approximately two orders of magnitude drop in activity upon oxidation. The degree of the oxidation could in principle be followed on SDS-PAGE gels, because the oxidized form is more compact and travels further through the gel. This is true, however, if the polypeptide chain between both cysteines is of sufficient length and, therefore, cannot be reliably used for all of the mutants studied here. As an example, three mutants from the N-terminal part are shown in Fig.  3B . All three were not hemolytically active in the oxidized form (Figs. 3A and 4) due to the formation of a disulfide bridge that prevented helix A from participating in pore formation. However, the shift in mobility for oxidized form was not observed for 22-34 and was similar for 8 -69 and 7-72 (Fig. 3B) . We could not, therefore, rely on Western blots for the confirmation of disulfide formation. We assumed that they were formed in the majority of mutants, because they were predicted by modeling (see "Experimental Procedures"). To check this for a mutant from the helix B region, mutant 103-136 was chosen and purified from the bacterial supernatant. Helix B is supposed to be locked to the ␤-strand 7 of the sandwich in the oxidized state, therefore, changes in activity would report proposed conformational changes in this region of the molecule (12) . This mutant did not show any change in the activity in either state, but the disulfide was actually formed (see later). Mutant 54 -87 was also purified, as the only one that was more active in the oxidized form, and we wanted to get an insight into the reasons for such a behavior. A positive control was mutant 8 -69, where block of conformational change in the N-terminal region prevented the activity (13) .
Mutants were purified to homogeneity from the bacterial cytoplasm. The far-UV CD spectra of mutants in both states resembled that of the wild-type (data not shown) indicating a lack of structural perturbations due to induced mutations. The formation of disulfides was checked with SDS-PAGE (Fig. 5A) . A shift in mobility can be observed for all three mutants. As expected and explained above, the largest shift in mobility was observed for 8 -69 and smaller ones for 54 -87 and 103-136. b ␤, beta strand; h, helix. Loops between the strands or helices are written without hyphens.
c C ␤ -C ␤ distances were determined by using the SSBond program (28) and from the crystal structure of EqtII (11) (PDB code 1IAZ).
d Hemolytic activity shown is relative to the wild-type in reduced conditions (final 2 mM DTT): ϩϩ, more than 25% of wild-type's activity; ϩ, 3-25% of wild-type activity; Ϫ, Ͻ3% of wild-type activity or not hemolytically active.
e C ␣ -C ␤ distance is shown. These results were confirmed with proteolysis, where a different pattern of proteolytic fragments was observed on SDS-PAGE gels for reduced and oxidized states (data not shown). We also determined the crystal structure of the 8 -69 mutant (PDB code 1TZQ). The disulfide 8 -69 is well defined in the electron density maps, whereas the rest of the structure remained almost identical to the structure of the wild-type (11) . The root mean square difference between pairs of C␣ atoms in both structures is 0.54 Å.
FIG. 2. The expression and hemolytic activity of disulfide mutants. A, 15% SDS-PAGE gel stained by
The hemolytic activity of 103-136 was similar in both states, but slightly reduced in comparison to that of the wild-type. (Fig.  5B ). The loss of activity was confirmed for this mutant by a permeabilizing assay. Although the reduced mutant was completely inactive, the oxidized form showed some residual activity, but considerably less than the wild-type (Fig. 5C ). This considerable decrease in activity of the reduced state of 54 -87 is due to reduced binding. The binding to bovine red blood cells was checked by Western blotting (Fig. 5B, inset) . As expected, mutant 103-136 exhibited similar binding in both conditions, because the introduced mutations are located in regions far from the tryptophan rich-region at the bottom of the molecule. In 54 -87, however, we consistently observed slightly less binding in the reduced state (Fig. 5B ). In the reduced state this mutant also inserts less in the monolayers composed of PC/SM 1/1, a method that proved to be extremely useful in actinoporins membrane binding studies (13, 18) . The critical pressure plots, as shown in Fig. 5D , are constructed from the changes of the surface pressure increment originated by the insertion of the toxin at different initial pressures. From these plots it is possible to determine the critical pressures, i.e. pressures at which no insertion can occur. With 54 -87 critical pressures of 27.7 mN/m and 29.1 mN/m were determined for the reduced and oxidized states, respectively (Fig. 5D) , and can be compared with the 36.5 mN/m value determined for the wild-type. Mutagenesis of Tryptophan 117-In summary, by the use of double cysteine mutants we have shown that the major conformational rearrangements of EqtII, which occur during pore formation, are restricted to the N-terminal region. Results also implicate that the ␤-sandwich and helix B do not undergo gross conformational changes and probably remain intact during the pore formation. Mutations at position 117 were created and assayed for activity and stability, to independently assess the importance of the ␤-sandwich stability. (Fig. 1, A-C) . Any changes in the packing of the novel side chain introduced by the mutation of Trp 117 would presumably destabilize this side of ␤-sandwich. If the hydrophobic core undergoes gross conformational changes during the pore formation, the reduced stability could enhance the activity, as was observed for some other ␣-PFTs (38, 39) .
Five mutants were prepared. Two introduced charged groups in the interior of the protein (W117R and W117D). In addition, aromatic (W117F), hydrophobic (W117V), and small (W117G) side chains were probed. Although the expression level was similar for all mutants (data not shown), only W117F and W117G could be isolated in sufficient amounts to perform detailed characterization. The yields for these two mutants were 2.2 and 0.5 mg/liter culture and were less than the 5.5 mg/liter culture of the wild-type. The W117R, W117D, and W117V were isolated at less than 0.03 mg/liter culture, because the mutations prevented the correct folding of the molecule, leading to accumulation of insoluble protein in the cytoplasm. The structure of W117F and W117G was preserved according to the far-UV CD spectra (Fig. 6A) . Both mutants were similarly or slightly less active than the wild-type (Fig. 7) as judged by hemolysis and liposome permeabilization assays. They were both able to insert in the PC/SM 1/1 monolayers. Critical pres- sure values obtained were 35.3 mN/m for both mutants and comparable to the wild-type value of 36.5 mN/m. However, both mutants were considerably less stable than the wild-type EqtII. The stability was checked independently with ANS binding assay and following the CD signal at 217 nm while increasing the temperature (Fig. 6B) . The ANS assay yielded T m values of 47.4°C and 55°C for W117G and W117F, respectively. The unfolding followed by far-UV CD gave sigmoidal curves (inset in Fig. 6B) with T m values of 51.9°C and 56.2°C for W117G and W117F, respectively. This is well below wildtype EqtII and StII transitions around 65°C degrees observed in the same (Fig. 6B ) and other assays, e.g. differential scanning calorimetry (40, 41) .
DISCUSSION
In this report we define the regions of EqtII that undergo conformational transitions during the pore formation. This knowledge is essential to understand the formation of these 2-nm diameter pores in eukaryotic cell membranes. Based on this study, three-dimensional structure (11, 12) , and previous biochemical data (13, 15, 17, 20, 31) , we conclude that during pore formation (i) the conformational changes are restricted to the N-terminal region 1-30 and (ii) an intact ␤-sandwich is required. Our study also shows that the POC binding site and adjacent regions are particularly sensitive to mutation.
The Conformational Changes in the N-terminal RegionWith one exception, all mutants from the N-terminal region were considerably less hemolytically active when the disulfide was formed between the N-terminal region and the ␤-sandwich. Taking into account also other functional studies (13, 15, 31) we can now propose that the N-terminal region 1-30 requires conformational flexibility during pore formation. It would be possible that residues used for attachment of the N-terminal region from the ␤-sandwich face are also important for hemolytic activity and that region 30 -72 undergoes some conformational rearrangements as well. However, in the reduced form most of the double cysteine mutants exhibited similar activity as that of the wild-type protein. The only exception was 14 -70, indicating a role for one of these two or both residues. Our reasons for concluding that the ␤-sandwich face probably does not undergo conformational change are outlined below.
Our results, therefore, have an implication for the structure of the final pore. The actinoporins are bound to the membrane only superficially in the first step of the pore formation, mainly by exposed Trp 112 and POC binding site (13, 17) . The only so far recognized structural part that is inserted deeper in the membrane is the region 10 -28 (15, 31) forming the amphipathic ␣-helix in such a way that the polar face is oriented to the pore lumen and the hydrophobic face to the acyl chains of the lipid bilayer. As this study now makes clear, the conformational changes are restricted solely to the 1-30 N-terminal region of the molecule, and it is unlikely that other parts of the molecule participate in the formation of the pore walls. These results then strongly support a model where the final pore is formed by ␣-helices and bilayer lipids, because no other part of EqtII inserts sufficiently deeply into the membrane to fill the remain- ing gaps between the helices (16, 42) . Such protein-lipid pores were also proposed for smaller pore-forming peptides such as melittin (43) or larger proteins such as apoptotic Bax proteins (44, 45) .
The Compact ␤-Sandwich Is Required for Pore FormationOur double cysteine data imply that no changes of the ␤-sandwich structure are necessary for the pore formation, i.e. it remains compactly folded. Furthermore, mutants that destabilize one side of the sandwich do not have increased activity as would be expected if considerable unfolding of the ␤-sandwich occurs during the pore formation. This was shown for colicins, another ␣-PFT group from E. coli. Colicin pore-forming domains are composed of three layers of ␣-helices. The middle layer consists of a hydrophobic helical hairpin, which is inserted into the membrane during pore formation when the molecule unfolds on the surface (8, 46) . Mutations that destabilize the protein to form a molten globule usually increase the rate of membrane insertion (38, 39) . We have a completely different situation in the case of EqtII. Despite considerable destabilization of the hydrophobic core of the protein, the activity and insertion are not enhanced but actually slightly lower or on the same level as of that of the wild-type (Fig. 7) . We propose that the stable ␤-sandwich core with exposed aromatic cluster is needed to attach the toxin to the membrane and for subsequent oligomerization. It does not change conformation during the pore formation, and, consequently, its parts do not participate in building of transmembrane pore walls.
Two previous observations are in agreement with our proposition. It was shown by CD and Fourier transform-IR spectroscopy that the secondary structure content of actinoporins hardly changes when they bind to the membrane (47) (48) (49) . Specifically, ␣-helical and ␤-sheet content are increased by a few percent at the expense of random structure. The observed increase in ␣-helical content was attributed to a folding of region 10 -16 when the N-terminal region was associated with the membrane (15) . The rest of the structure, therefore, does not significantly change. The lack of unfolding of actinoporin ␤-sandwich after membrane association was observed also by electron microscopy of StII two-dimensional crystals on lipid monolayers (17) . Oligomeric structures were observed composed of four units. These were ascribed to individual StII molecules and could be fitted into electron density solely by rotating the N-terminal region away from the intact ␤-sandwich.
Use of a small domain rich in ␤-structure is apparently a general concept in the protein-membrane attachment as many examples of such membrane-binding domains are being described (2-4, 50 -52). Other functions are then performed by additional domains of the membrane-attached protein. In an example from the PFTs, domain four of (the cholesterol-dependent cytolysin) perfringolysin, which shows structural similarity with EqtII ␤-sandwich (11, 53) , is used to attach the toxin to a membrane surface (52) . Meanwhile the pore is formed by two pairs of helices from domain 3 that change conformation and form transmembrane ␤-barrel together with other monomers (54, 55) . In heptameric ␤-PFTs (␣-hemolysin, anthrax toxin, etc.) the ␤-strands for the pore are formed from previously unfolded or flexible loop regions. Thus ␣-helices or unfolded structures can easily rearrange to form new membrane-bound forms, but no cases of rearrangement of previously stable ␤-strand structures have been reported. Here we test the hypothesis directly, and again no role for destabilized ␤-structure was found. The fundamental reliance of ␤-domains upon intricate hydrogen bonding patterns makes rearrangement unfavorable, and thus they are often the stable endpoint of protein rearrangement (prions, amyloid, etc.) (56) rather than the start.
Activity of Mutant 54 -87-An interesting mutant, 54 -87, was also found, with activity largely restored only when the disulfide was formed. Positions 54 and 87 are located on the bottom of the molecule (Fig. 1) connecting ␤-strands 3 and 6, very close to the membrane binding site (11) . It was shown previously that a single cysteine mutant, S54C, was less active than the wild-type, with even further loss of activity observed when the thiol group was chemically modified to add positive or negative charge (47) . Similarly, mutant 54 -87 retained 6% of its activity when both cysteines were chemically modified with iodoacetic acid introducing negative charge (data not shown). The reduction in activity was, however, not as complete as for some double cysteine mutants from the N-terminal region, which prevent helix A transfer to the membrane. Instead, in 54 -87 the activity is modulated by the degree of initial binding to the membrane as viewed on blots of the BRBC-bound mutant or insertion in lipid monolayers (Fig. 5, B and D) . Thus these two residues clearly have a role in the first membrane-binding step. They might not directly interact with the membrane, because Ser-54 was not recognized in a previous cysteine scan as a residue required for membrane interaction (31) . Instead, they might change properties of the nearby POC binding site. Remarkably, all residues of the proposed POC binding site of StII are conserved in the EqtII structure (17 54 and Val 87 . The properties of the cavity might change by mutating Ser54 and Val87 to cysteines and, consequently, binding of POC moiety. Especially, because, under the conditions used for hemolytic assays (pH 7.4) and calcein release experiments (pH 8.5), a thiol group (pK a 8.7) carries a partial negative charge that changes the properties of the cavity. By contrast, the disulfide partially restores the POC site properties, efficient binding, and consequently hemolysis. Furthermore, we observed no hemolytic activity for mutants 87-105 and 107-113, where residues of the POC binding site were mutated to cysteines. And finally, mutants where residues close to the POC pocket were mutated were not active (118 -136) or had less activity than the wild-type, as was the case for isolated 103-136. The POC cavity is, therefore, very sensitive to the local change.
The Activity of Mutants from Broad Loops-The region composed of the broad loops at the bottom of the molecule was the most sensitive to introduced mutations. All mutants from that region were not hemolytically active ( Fig. 2 and Table I ) and could not be used in the disulfide scan. Single-cysteine mutants of this region that showed considerably lower hemolytic activity, R31C, and K77C, S114C and S167C, have been already described (31) . This clearly shows that the primary structure of the loops needs to be preserved and that mutations in loops close to functional parts of the toxin, i.e. the N-terminal region or Trp 112 and POC, site are not favored. This is also in agreement with a recent proposal by Mancheñ o et al. (17) of the important functional role that these loops have during the pore formation.
In conclusion, using disulfide scanning mutagenesis we have determined the regions of EqtII that change conformation during the pore-forming mechanism. These are restricted to the N-terminal region of the molecule. The hydrophobic core, instead, remains structurally unchanged and provides a rigid structural framework for residues that enable binding of POC and attachment of the toxin to the membrane and probably to its neighbors in the oligomer.
